S&P, thanks for your thoughts -
I take it that your effort to miscast my comments is a personal attack, as opposed to a reasoned discussion of what I really said. Fine with me.
DMX is a company that has only two products approaching saleable status.
It's your contention that investors don't give a rat's ass how, or whether, these products work. "They are concerned with larger things, such as fundamentals, management, debt, market potential, etc."
I submit that how, and whether, these two products work are central to the fundamentals, and central to the market potential. Understanding the products is pivotal to understanding the regulatory hurdles, to the different jurisdictional attitudes, to the difficulties with trials, and the revenue potential of the company.
Or, not. According to you, it's just Blue Goo, you don't need a clue. "Psssst! I've got some MBI for ya, buddy!"
Does this stuff work?
"Don't you investors worry your fuzzy little heads about that. It's beyond you. Trust us."
Yep. A formula for investor success.
Signed,
Blinded by the Light |
